FaribaNavidMD

Clinical Trials

• Osteosarcoma1999-A Study Of Intensive Chemotherapy for Osteosarcoma Start of enrollment: 1999 May 01

  Completed

  Phase 2

• Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma Start of enrollment: 2008 May 09

  Active, not recruiting

  Phase 2

• Phase I Study of Bevacizumab and Sorafenib Combined With Low Dose Cyclophosphamide in Patients With Refractory Solid Tumors and Leukemia Start of enrollment: 2007 Nov 01

  Completed

  Phase 1

• A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma Start of enrollment: 2008 Jun 03

  Completed

  Phase 2

• A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma Start of enrollment: 2008 Oct 08

  Completed

  Phase 1

• Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy Start of enrollment: 2010 Dec 01

  Completed

  Phase 2

• Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors Start of enrollment: 2013 Dec 27

  Active, not recruiting

  Phase 2

• Pretreatment Anti-Therapeutic Antibodies (PATA) in Patients Treated With hu14.18K322A Antibody Start of enrollment: 2014 Jul 15

  Completed

• A Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by Surgery Start of enrollment: 2020 Oct 07

  Active, not recruiting

  Phase 2

• SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma Start of enrollment: 2021 Jun 04

  Active, not recruiting

  Phase 2

• Join now to see all